Cleared Traditional

K082134 - CIRCULATOR BOOT

K082134 is the FDA 510(k) clearance for CIRCULATOR BOOT by Circulator Boot Corp.. It is a Class 2 Cardiovascular device (product code DRN) cleared through the Traditional 510(k) pathway after a 282-day FDA review.

K082134 · Circulator Boot Corp. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2009
Decision
282d
Days
Class 2
Risk

K082134 is an FDA 510(k) clearance for the CIRCULATOR BOOT. Classified as Device, Counter-pulsating, External (product code DRN), Class II - Special Controls.

Submitted by Circulator Boot Corp. (Malvern, US). The FDA issued a Cleared decision on May 7, 2009 after a review of 282 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.5225 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Circulator Boot Corp. devices

Submission Details

510(k) Number K082134 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 29, 2008
Decision Date May 07, 2009
Days to Decision 282 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
157d slower than avg
Panel avg: 125d · This submission: 282d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DRN Device, Counter-pulsating, External
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.5225
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.